A column chart showing the five states that received the most venture capital funding allocations to biopharma companies in the first two quarters of 2025: California ($5.53 billion), Massachusetts ($2.75 billion), Washington ($456 million), Illinois ($449 million), and North Carolina ($447 million). Massachusetts is shown in red, while all other states are shown in blue.